vxa101

Vitali Alexeev, PhD

Contact Dr. Alexeev

233 S. 10th Street
Room 319
Philadelphia, PA 19107

(215) 503-4835

Most Recent Peer-reviewed Publications

  1. Prime-boost immunization eliminates metastatic colorectal cancer by producing high-Avidity effector CD8+ T cells
  2. Misbalanced CXCL12 and CCL5 Chemotactic Signals in Vitiligo Onset and Progression
  3. Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment
  4. Chemotaxis-driven disease-site targeting of therapeutic adult stem cells in dystrophic epidermolysis bullosa
  5. Reaction Chemistry Generated by Nanosecond Pulsed Dielectric Barrier Discharge Treatment is Responsible for the Tumor Eradication in the B16 Melanoma Mouse Model
  6. Fibulin-4 E57K knock-in mice recapitulate cutaneous, vascular and skeletal defects of recessive cutis laxa 1B with both elastic fiber and collagen fibril abnormalities
  7. The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice
  8. Targeting the mRNA-binding protein HuR impairs malignant characteristics of pancreatic ductal adenocarcinoma cells
  9. Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound
  10. Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophy
  11. Chemokine-enhanced DNA vaccination in cancer immunotherapy
  12. Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine
  13. Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues
  14. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy
  15. Gene expression signatures of mouse bone marrow-derived mesenchymal stem cells in the cutaneous environment and therapeutic implications for blistering skin disorder
  16. Targeted manipulation of mammalian genomes using designed zinc finger nucleases
  17. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential
  18. Retroviral delivery of ECM genes.
  19. MicroRNA-dependent regulation of cKit in cutaneous melanoma
  20. Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells